Much of the general public believes oncology is a “sad” field. Amol Narang, and many other practicing oncologists, disagree. Learn about his inspiring profession and why he would choose to be an oncologist time and time again.
Epigenetic drugs are an emerging class of cancer therapeutics. In this article, Ph.D. candidate Roshan Chikarmane introduces Foghorn Therapeutics, its co-founder, Cigall Kadoch, and the science behind their drug development program.
Dec 2, 2020
A medical student reflects on a recent encounter with a patient who shared painful details of his life for the first time.
Nov 30, 2020
Feeling burned out? You are not alone. With so much time spent indoors, it is more important than ever to connect with nature. Research has shown that adding houseplants to your surroundings can improve your mood as well as your ability to learn, concentrate and be productive.
Nov 27, 2020
The COVID-19 pandemic has impacted healthcare systems in many ways beyond direct care of COVID-19 patients. One disruption lies in the public health infrastructure for reporting of infectious diseases, such as sexually transmitted infections (STIs).
Nov 25, 2020
Three medical students at the Johns Hopkins University School of Medicine recently published an article in response to an important decision that will change how applicants to medical residency programs will be evaluated beginning in 2022.
Nov 23, 2020
Every year, a new crop of interns at Johns Hopkins Bayview Medical Center creates an oath, a “North Star” to help guide us through residency and reaffirm our collective commitment to humanism and professionalism. This year it will be a bit different.
Nov 20, 2020
With cold and flu season fast approaching, the push to vaccinate communities against influenza is greater than ever. Meanwhile, COVID-19 vaccine trials are working furiously to release a winning candidate by the end of the year.
Nov 11, 2020